EMCURE
Invest with MTF
Invest Now
Invest in Emcure Pharmaceuticals with 3.3X leverage
Emcure Pharmaceuticals live price: ₹1415.8. It opened at ₹1,456 vs previous close ₹1,453; intraday high/low: ₹1,477/₹1,412. The 50 & 200 DMA stand at ₹1,460.04/₹1,397.12.
Emcure Pharmaceuticals Performance
- Low
- ₹1,412
- High
- ₹1,477
- 52 Week Low
- ₹889
- 52 Week High
- ₹1,586
- Open Price₹1,456
- Previous Close₹1,453
- Volume104,906
- 50 DMA₹1,460.04
- 100 DMA₹1,435.01
- 200 DMA₹1,397.12
Investment Returns
- Over 1 Month -6.59%
- Over 3 Month + 1.4%
- Over 6 Month + 3.14%
- Over 1 Year + 45.87%
Smart Investing Starts Here Start SIP with Emcure Pharmaceuticals for Steady Growth!
Emcure Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 30.9
- PEG Ratio
- 0.7
- Market Cap Cr
- 26,842
- P/B Ratio
- 5.4
- Average True Range
- 52.08
- EPS
- 47.73
- Dividend Yield
- 0.2
- MACD Signal
- -9.75
- RSI
- 40.48
- MFI
- 65.89
Emcure Pharmaceuticals Financials
Emcure Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,415.80
-37.6
(-2.59%)
- Bearish Moving Average 13
- Bullish Moving Average 3
- 20 Day
- ₹1,457.99
- 50 Day
- ₹1,460.04
- 100 Day
- ₹1,435.01
- 200 Day
- ₹1,397.12
Resistance and Support
1434.97
- R3 1,522.43
- R2 1,499.67
- R1 1,457.73
- S1 1,393.03
- S2 1,370.27
- S3 1,328.33
Emcure Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Emcure Pharmaceuticals F&O
About Emcure Pharmaceuticals
- NSE Symbol
- EMCURE
- BSE Symbol
- 544210
- Managing Director & CEO
- Mr. Satish Ramanlal Mehta
- ISIN
- INE168P01015
Similar Stocks to Emcure Pharmaceuticals
Emcure Pharmaceuticals FAQs
Emcure Pharmaceuticals share price is ₹1,415 As on 08 March, 2026 | 07:43
The Market Cap of Emcure Pharmaceuticals is ₹26842.1 Cr As on 08 March, 2026 | 07:43
The P/E ratio of Emcure Pharmaceuticals is 30.9 As on 08 March, 2026 | 07:43
The PB ratio of Emcure Pharmaceuticals is 5.4 As on 08 March, 2026 | 07:43
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.